
<!DOCTYPE html>

<html lang="en">
<!-- Faster page load hack -->
<!--[if IE]><![endif]-->
<head>
<!-- Begin: head -->
<!-- z2_comm_head_module_v2 start -->
<meta charset="utf-8"/>


<!-- Combined and Minified CSS file for all generator pages -->
<link href="https://staticx.zacks.com/min/z3-min.css?v=20241119" rel="stylesheet"/>
<link href="https://staticx.zacks.com/css/zacks/css2/global-print.css?v=20241119" media="print" rel="stylesheet" type="text/css"/>
<!-- Conditional CSS for IE versions -->
<!--[if lt IE 7]><style type="text/css"> .hide_lte_ie6 { display:none; } </style><![endif]-->
<!--[if lte IE 7]><style type="text/css"> .hide_lte_ie7 { display:none; } </style><![endif]-->
<!--[if lte IE 8]><style type="text/css"> .hide_lte_ie8 { display:none; } </style><![endif]-->
<!--[if lte IE 9]><style type="text/css"> .hide_lte_ie9 { display:none; } </style><![endif]-->
<!--[if IE 10]><style type="text/css"> .hide_lte_ie10 { display:none; } </style><![endif]-->
<!--[if IE]><![endif]-->
<!-- End conditional CSS for IE versions -->
<!-- DC PAGE ID : 194  -->
<meta content="WebGenerator" name="generator"/>
<meta content="Lilly (LLY) signs deal with AbCellera to co-develop antibody therapies to treat COVID-19. AbbVie (ABBV) supports studies evaluating Kaletra for treating COVID-19." name="description"/>
<meta content="stock, stocks, investment, investment advice, investing, online trading, online investment, online stock trading, stock market, financial, financial planning, quote, quotes, stock quotes" name="keywords"/>
<title>Pharma Stock Roundup: ABBV, LLY Coronavirus Product Development Efforts, FDA Updates - March 13, 2020 - Zacks.com</title>
<meta content="Tue, 19 Nov 2024 09:07:25" name="date"/>
<meta content="Tue, 19 Nov 2024 09:07:25;" name="last-modified"/>
<meta content="Tue, 19 Nov 2024 09:07:25" http-equiv="last-modified"/>
<meta content="20922385" property="fb:admins"/>
<meta content="https://www.facebook.com/ZacksInvestmentResearch" property="article:publisher"/>
<meta content="Zacks Investment Research" property="og:site_name"/>
<meta content="Pharma Stock Roundup: ABBV, LLY Coronavirus Product Development Efforts, FDA Updates" property="og:title"/>
<meta content="article" property="og:type"/>
<meta content="https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg" property="og:image"/>
<meta content="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates" property="og:url"/>
<meta content="Lilly (LLY) signs deal with AbCellera to co-develop antibody therapies to treat COVID-19. AbbVie (ABBV) supports studies evaluating Kaletra for treating COVID-19." property="og:description"/>
<meta content="summary_large_image" name="twitter:card"/>
<meta content="@ZacksInvestment" name="twitter:site"/>
<meta content="Pharma Stock Roundup: ABBV, LLY Coronavirus Product Development Efforts, FDA Updates" name="twitter:title">
<meta content="https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg" name="twitter:image">
<meta content="Lilly (LLY) signs deal with AbCellera to co-develop antibody therapies to treat COVID-19. AbbVie (ABBV) supports studies evaluating Kaletra for treating COVID-19." name="twitter:description"/>
<meta content="ABBV, AbbVie Inc., AZN, AstraZeneca PLC, BMY, Bristol Myers Squibb Company, JNJ, Johnson &amp; Johnson, LLY, Eli Lilly and Company, MRK, Merck &amp; Co., Inc., RHHBY, Roche Holding AG, Business,Markets,Investing,Stocks,Stock Market,Stock Market News,Business News " name="news_keywords"/>
<meta content="91D8CCE675E89439C48AA39EBAF6988D" name="msvalidate.01">
<!-- Article Structured Data -->

<link href="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates" rel="canonical"/>
<meta content="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates" name="syndication-source"/><meta content="app-id=731593509" name="apple-itunes-app"/>
<!-- used by smart phones and tables -->
<meta content="Zacks Investment Research" name="author">
<meta content="Â© 2013 Zacks Investment Research" name="copyright">
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="https://staticx.zacks.com/images/zacks/logos/favicon_1x_16x16.ico" rel="icon" type="image/x-icon"/>
<link href="https://staticx.zacks.com/images/zacks/logos/favicon_1x_16x16.ico" rel="shortcut icon" type="image/x-icon"/>
<!-- For non-Retina iPhone, iPod Touch, and Android 2.1+ devices: -->
<link href="https://staticx.zacks.com/images/zacks/logos/logo_apple-touch-icon-57x57precomposed.png" rel="apple-touch-icon-precomposed"/>
<!-- For first- and second-generation iPad: -->
<link href="https://staticx.zacks.com/images/zacks/logos/logo_apple-touch-icon-72x72precomposed.png" rel="apple-touch-icon-precomposed" sizes="72x72"/>
<!-- For iPhone with high-resolution Retina display: -->
<link href="https://staticx.zacks.com/images/zacks/logos/logo_apple-touch-icon-114x114-precomposed.png" rel="apple-touch-icon-precomposed" sizes="114x114"/>
<!-- For third-generation iPad with high-resolution Retina display: -->
<link href="https://staticx.zacks.com/images/zacks/logos/logo_apple-touch-icon-144x144-precomposed.png" rel="apple-touch-icon-precomposed" sizes="144x144"/>
<!-- DC Page id : 194 -->
<!--[if IE]>
<script async src="https://staticx.zacks.com/js/html5shiv.js"></script>
<![endif]-->
<!-- z2_head_v2.phtml -->








<link href="https://staticx.zacks.com/css/zacks/css3/styles/commentary-main.css?v=20241119" media="all" rel="stylesheet" type="text/css"/><!-- investing channel adcode -->



<!-- z2_comm_head_module_v2 end -->
<!-- End: head -->
</meta></meta></meta></meta></meta></head>
<body>
<!-- Begin: top_navigation-->
<!-- z2_top_nav start -->
<div class="skipnav"><a href="#main_content">Skip to main content</a></div>
<div aria-label="Cookie Consent" class="disclosure-fixed-slab" role="region">
<p>We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, <a href="https://www.zacks.com/privacy.php#how-to-use-cookies">click here</a>. By continuing to use our site, you accept our use of cookies, revised <a href="/privacy.php">Privacy Policy</a> and <a href="/terms_of_service">Terms of Service</a>.</p>
<div><button id="accept_cookie" name="accept_cookie">I accept</button><button aria-label="Close" class="close">X</button></div>
</div>
<!-- Disclosure message id 23007 --><!--MSG:23007-->
<div id="sticky_head">
<div class="primary-nav--wrapper">
<section class="clearfix top-header-section">
<div class="header-logos"><a class="mobile_logo" href="/" rel="home" role="link"><img alt="Zacks Investment Research Home" height="57" src="https://staticx.zacks.com/images/zacks/logos/zacks_logo_200x57.png" title="" width="200"/></a> </div>
<ul class="user-menu_list"></ul>
</section>
<header class="primary-nav--content">
<nav aria-label="main" class="sticky" id="primary">
<!-- nav toggle trigger for mobile -->
<button aria-controls="navbar-collapse" aria-expanded="false" class="toggle-navbar" data-toggle="collapse" title="Toggle header navigation" type="button">
<span class="z1-mobile-menu">Menu</span>
<span class="sr-only">Toggle header navigation</span>
</button>
<ul class="navbar-collapse" id="navbar-collapse">
<li class="">
<a aria-current="page" href="//www.zacks.com">Home</a>
</li>
<li class="with-dd">
<a class="mobile-disable" href="//www.zacks.com/stocks.php" id="stocks-dd">Stocks</a>
<!-- stocks dd -->
<button aria-controls="stocks-menu" aria-expanded="false" class="toggle-button sr-only sr-only-focusable">
<i aria-hidden="true" class="fa fa-plus"></i><i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Stocks</span>
</button>
<ul aria-labelledby="stocks-dd" class="menu" id="stocks-menu">
<li><a href="//www.zacks.com/stocks.php">Stocks</a></li>
<li><a href="//www.zacks.com/stocks/buy-list/?adid=zp_topnav_1list">Zacks #1 Rank</a></li>
<li><a href="//www.zacks.com/stocks/zacks-rank">Zacks Rank</a></li>
<li><a href="//www.zacks.com/stocks/industry-rank/industries/">Zacks Industry Rank</a></li>
<li><a href="//www.zacks.com/stocks/industry-rank/sectors/">Zacks Sector Rank</a></li>
<li><a href="//www.zacks.com/stocks/equity-research">Equity Research</a></li>
<li><a href="//www.zacks.com/stock-market-today">Markets</a></li>
</ul>
</li>
<li class="with-dd">
<a class="mobile-disable" href="//www.zacks.com/funds/" id="funds-dd">Funds</a>
<!-- stocks dd -->
<button aria-controls="funds-menu" aria-expanded="false" class="toggle-button sr-only sr-only-focusable">
<i aria-hidden="true" class="fa fa-plus"></i><i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Funds</span>
</button>
<ul aria-labelledby="funds-dd" class="menu" id="funds-menu">
<li><a href="//www.zacks.com/funds/">Funds</a></li>
<li><a href="//www.zacks.com/funds/mutual-funds">Mutual Funds</a></li>
<li><a href="//www.zacks.com/funds/etfs">ETFs</a></li>
<li><a href="//www.zacks.com/screening/mutual-fund-screener">Mutual Fund Screener</a></li>
<li><a href="//www.zacks.com/screening/etf-screener">ETF Screener</a></li>
<li><a href="//www.zacks.com/funds/top-etfs">Top ETFs</a></li>
</ul>
</li>
<li class="">
<a href="//www.zacks.com/cryptocurrency">Crypto</a>
</li>
<li class="with-dd">
<a class="mobile-disable" href="//www.zacks.com/earnings" id="earnings-dd">Earnings</a>
<!-- stocks dd -->
<button aria-controls="earnings-menu" aria-expanded="false" class="toggle-button sr-only sr-only-focusable">
<i aria-hidden="true" class="fa fa-plus"></i><i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Earnings</span>
</button>
<ul aria-labelledby="earnings-dd" class="menu" id="earnings-menu">
<li><a href="//www.zacks.com/earnings">Earnings</a></li>
<li><a href="//www.zacks.com/earnings/earnings-calendar">Earnings Calendar</a></li>
<li><a href="//www.zacks.com/earnings/earnings-reports">Earnings Releases</a></li>
<li><a href="//www.zacks.com/earnings/earnings-surprise-predictions/">Earnings ESP</a></li>
<li><a href="//www.zacks.com/premium/esp-buy?adid=zp_topnav_espfilter">Earnings ESP Filter</a></li>
</ul>
</li>
<li class="with-dd">
<a class="mobile-disable" href="//www.zacks.com/screening" id="screening-dd">Screening</a>
<!-- stocks dd -->
<button aria-controls="screening-menu" aria-expanded="false" class="toggle-button sr-only sr-only-focusable">
<i aria-hidden="true" class="fa fa-plus"></i><i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Screening</span>
</button>
<ul aria-labelledby="screening-dd" class="menu" id="screening-menu">
<li><a href="//www.zacks.com/screening">Screening</a></li>
<li><a href="//www.zacks.com/screening/stock-screener">Stock Screener</a></li>
<li><a href="//www.zacks.com/screening/mutual-fund-screener">Mutual Fund Screener</a></li>
<li><a href="//www.zacks.com/screening/etf-screener">ETF Screener</a></li>
<li><a href="//www.zacks.com/screening/premium-screens">Premium Screens</a></li>
<li><a href="//www.zacks.com/screening/basic-screens/">Basic Screens</a></li>
<li><a href="//www.zacks.com/screening/thematic-screens/">Thematic Screens</a></li>
<li><a href="//www.zacks.com/researchwizard/index.php?site=screen">Research Wizard</a></li>
</ul>
</li>
<li class="with-dd">
<a class="mobile-disable" href="//www.zacks.com/finance/" id="finance-dd">Finance</a>
<!-- stocks dd -->
<button aria-controls="finance-menu" aria-expanded="false" class="toggle-button sr-only sr-only-focusable">
<i aria-hidden="true" class="fa fa-plus"></i><i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Finance</span>
</button>
<ul aria-labelledby="finance-dd" class="menu" id="finance-menu">
<li><a href="//www.zacks.com/finance/">Personal Finance</a></li>
<li><a href="//www.zacks.com/personal-finance/583/Money-Management">Money Management</a></li>
<li><a href="//www.zacks.com/personal-finance/585/Retirement-Planning">Retirement Planning</a></li>
<li><a href="//www.zacks.com/personal-finance/586/Tax-Information">Tax Information</a></li>
</ul>
</li>
<li class="with-dd">
<a class="mobile-disable" href="//www.zacks.com/portfolios/my-stock-portfolio/" id="portfolio-dd">Portfolio</a>
<!-- stocks dd -->
<button aria-controls="portfolio-menu" aria-expanded="false" class="toggle-button sr-only sr-only-focusable">
<i aria-hidden="true" class="fa fa-plus"></i><i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Portfolio</span>
</button>
<ul aria-labelledby="portfolio-dd" class="menu" id="portfolio-menu">
<li><a href="//www.zacks.com/portfolios/my-stock-portfolio/">My Portfolio</a></li>
<li><a href="/portfolios/my-stock-portfolio?mode=create-new-portfolio">Create Portfolio</a></li>
</ul>
</li>
<li class="with-dd">
<a class="mobile-disable" href="//www.zacks.com/education/stock-education" id="edu-dd">Education</a>
<!-- stocks dd -->
<button aria-controls="edu-menu" aria-expanded="false" class="toggle-button sr-only sr-only-focusable">
<i aria-hidden="true" class="fa fa-plus"></i><i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Education</span>
</button>
<ul aria-labelledby="edu-dd" class="menu" id="edu-menu">
<li><a href="//www.zacks.com/education/stock-education">Stocks</a></li>
<li><a href="//www.zacks.com/style-scores-education/">Style Scores</a></li>
<li><a href="//www.zacks.com/education/mutual-fund-education">Funds</a></li>
<li><a href="//www.zacks.com/education/esp-education/">Earnings ESP</a></li>
<li><a href="//www.zacks.com/education/screening-education">Screening</a></li>
<li><a href="//www.zacks.com/reviews">Testimonials</a></li>
<li><a href="//www.zacks.com/start-here">Zacks.com Tutorial</a></li>
</ul>
</li>
<li class="">
<a href="//www.zacks.com/financial-videos/index.php">Video</a>
</li>
<li class="">
<a href="//www.zacks.com/podcasts/">Podcasts</a>
</li>
<li class="services-mm">
<button aria-controls="services-menu" aria-expanded="false" class="toggle-button" id="services-dd">
                        Services
                        <i aria-hidden="true" class="fa fa-plus"></i>
<i aria-hidden="true" class="fa fa-caret-down"></i>
<span class="sr-only">Services</span>
</button>
<div aria-labelledby="services-dd" class="mega-menu" id="services-menu" role="region">
<!-- mega menu close btn -->
<button class="close-btn">
<i aria-hidden="true" class="fa fa-times"></i>
<span class="sr-only">Close Services menu</span>
</button>
<div class="col premium">
<a class="heading" href="//www.zacks.com/investment-services/" id="cat-1-title">Services Overview</a>
<ul aria-labelledby="cat-1-title">
<li><a href="//www.zacks.com/ultimate/?adid=TOP_ONLINE_NAV">Zacks Ultimate</a></li>
<li><a href="//www.zacks.com/investorcollection/">Zacks Investor Collection</a></li>
<li><a href="//www.zacks.com/premium.php">Zacks Premium</a></li>
</ul>
</div>
<div class="col">
<h2 class="heading" id="cat-2-title">Investor Services</h2>
<ul aria-labelledby="cat-2-title">
<li><a href="//www.zacks.com/etfinvestor/">ETF Investor</a></li>
<li><a href="//www.zacks.com/homerun/?adid=TOP_ONLINE_NAV">Home Run Investor</a></li>
<li><a href="//www.zacks.com/incomeinvestor/">Income Investor</a></li>
<li><a href="//www.zacks.com/stocksunder10/">Stocks Under $10</a></li>
<li><a href="//www.zacks.com/valueinvestor/?adid=TOP_ONLINE_NAV">Value Investor</a></li>
<li><a href="//www.zacks.com/top-10-stocks.php">Top 10 Stocks</a></li>
</ul>
<h2 class="heading" id="cat-3-title">Other Services</h2>
<ul aria-labelledby="cat-3-title">
<li><a href="//www.zacks.com/registration/zmt/welcome/eoffer/33e3/?adid=TOP_ONLINE_NAV">Method for Trading</a></li>
<li><a href="//www.zacks.com/registration/rw/welcome/eoffer/3dd7/?adid=TOP_ONLINE_NAV">Research Wizard</a></li>
<li><a href="//www.zacks.com/confidential/?adid=TOP_ONLINE_NAV">Zacks Confidential</a></li>
</ul>
</div>
<div class="col">
<h2 class="heading" id="cat-4-title">Trading Services</h2>
<ul aria-labelledby="cat-4-title">
<li><a href="//www.zacks.com/blackboxtrader/">Black Box Trader</a></li>
<li><a href="//www.zacks.com/counterstrike/">Counterstrike</a></li>
<li><a href="//www.zacks.com/headlinetrader/">Headline Trader</a></li>
<li><a href="//www.zacks.com/insidertrader/">Insider Trader</a></li>
<li><a href="//www.zacks.com/largecaptrader/">Large-Cap Trader</a></li>
<li><a href="//www.zacks.com/optionstrader/">Options Trader</a></li>
<li><a href="//www.zacks.com/shortlist/">Short Sell List</a></li>
<li><a href="//www.zacks.com/surprisetrader/">Surprise Trader</a></li>
<li><a href="//www.zacks.com/tazr/">TAZR</a></li>
</ul>
<h2 class="heading" id="cat-5-title">Innovators</h2>
<ul aria-labelledby="cat-5-title">
<li><a href="//www.zacks.com/alternativeenergyinnovators/">Alternative Energy</a></li>
<li><a href="//www.zacks.com/blockchaininnovators/">Blockchain</a></li>
<li><a href="//www.zacks.com/commodityinnovators/">Commodity</a></li>
<li><a href="//www.zacks.com/healthcareinnovators/">Healthcare</a></li>
<li><a href="//www.zacks.com/marijuanainnovators/">Marijuana</a></li>
<li><a href="//www.zacks.com/technologyinnovators/">Technology</a></li>
</ul>
</div>
</div>
</li>
<!-- search container -->
<li class="search-container">
<form action="/search.php" autocomplete="off" id="search_form" method="post" name="frmsearch">
<label class="sr-only" for="search-q" id="header_search">Quote or Search</label>
<input aria-autocomplete="both" aria-controls="result_list_view" aria-expanded="false" aria-haspopup="listbox" autofocus="autofocus" class="dropdown" hasdefault="false" id="search-q" name="search-q" placeholder="Quote or Search" searchextras="all" type="search" value=""/>
<button type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
<span class="sr-only">Search</span>
</button>
<input class="search_mode" name="search_mode" type="hidden" value=""/>
<input class="ticker_type" name="ticker_type" type="hidden" value=""/>
<div class="result_container" id="result_list_view">
<div class="results_tickers"></div>
</div>
</form>

</li>
</ul>
</nav>
<div class="top_nav_spl_link">
<p class="top_special"><a href="https://www.zacks.com/start-here?icid=home-home-startHere-pfp-text_ribbon-tx_06" title="Get Started With Zacks"><span>New to Zacks?</span> Get started here.</a></p>
<ul aria-label="My Account" id="user_menu">
<li class="ad-block"><!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_88x31_1"></div></li>
<li><a href="https://www.zacks.com/registration_info.php">Join Now</a></li>
<li id="log_me_in">
<a aria-controls="log_me_in" aria-expanded="false" class="signin_expand" href="#">Sign In</a>
<!-- Begin: Login form -->
<div aria-label="Login" id="login_form" role="form">
<form action="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates" class="jslogin_form" method="post" name="jslogin_form" onsubmit="return JSloginCheck(this);">
<input class="hidden" name="force_login" type="hidden" value="true"/>
<h2>Member Sign In</h2>
<div class="form-field float-label">
<input autocomplete="username" id="username" name="username" placeholder="Username or Email Address" required="" type="text"/>
<label for="username">Username or Email Address</label>
</div>
<div class="form-field float-label">
<input autocomplete="password" class="password" id="password" name="password" placeholder="Password" required="" type="password"/>
<button class="password-toggle eye-ico-dark" toggle=".password" type="button"></button>
<label for="password">Password</label>
</div>
<div class="form-field">
<input checked="checked" id="rememberMe" name="remember_me" role="checkbox" type="checkbox"/> <label for="rememberMe">Keep Me Signed In</label>
<span class="remember_me help_me_link" onclick="alert('If you are the only one who uses your computer \nor if you are not concerned about keeping\nprivate information from the others who use \nyour computer (such as your spouse), you can \nselect the   âRemember Meâ option on the âLoginâ.\n\nWith this option you can move freely in and out \nof the Zacks Investment Research site with all \nits parts, and each time you return, \nZacks Investment Research will automatically sign \nyou in.\n\nFor your security you should keep your \nZacks Investment Research Member Name and\nPassword in a safe place so that you can refer to\nthem when you need to.\n\nThe Zacks Investment Research Team')">What does "Remember Me" do?</span>
</div>
<p><a class="forgotPasswordLink" href="/my-account/forgot.php?continue_to=%2F%2Fwww.zacks.com%2Fcommentary.php%3Farticle_id%3D811614%26type%3Dblog" role="link">Don't Know Your Password?</a></p>
<p><input class="fancy_button green" role="button" type="submit" value="Sign In"/></p>
<button aria-label="Close" id="close_login" role="button" tabindex="0" type="button">
<span class="sr-only">Close this window</span>
</button>
</form>
</div>
<!-- End: Login form -->
</li>
<li><a href="https://www.zacks.com/help/">Help</a></li>
</ul>
</div>
</header>
</div>
</div>
<div id="mobile_view"> <!-- nav toggle trigger for mobile -->
<header id="mob_sticky_head">
<div class="header_container">
<div class="header-top">
<a class="mobile_logo" href="/" rel="home" role="link"><img alt="Zacks Investment Research Home" height="57" src="https://staticx.zacks.com/images/zacks/logos/zacks_logo_200x57.png" title="" width="200"/></a>
<div class="auxiliary_menu">
<ul class="user-menu_list"><li><a href="https://www.zacks.com/registration_info.php">Join Now</a></li>
<li id="mob_log_me_in">
<a class="mobile_login_box" href="#">Sign In</a>
<!-- Begin: Login form -->
<div id="mob_login_form">
<form class="jslogin_form" method="post" name="jslogin_form" onsubmit="return JSloginCheck(this);">
<input class="hidden" name="force_login" type="hidden" value="true"/>
<h1>Member Sign In</h1>
<div class="form-field float-label">
<input autocomplete="username" id="username" name="username" placeholder="Username or Email Address" type="text"/>
<label for="username">Username or Email Address</label>
</div>
<div class="form-field float-label">
<input autocomplete="password" class="password" id="password" name="password" placeholder="Password" type="password"/>
<button class="password-toggle eye-ico-dark" toggle=".password" type="button"></button>
<label class="visuallyhidden" for="password">Password</label>
</div>
<div class="form-field">
<input checked="checked" id="rememberMe_m" type="checkbox"/> <label for="rememberMe_m">Keep Me Signed In</label>
</div>
<p><a class="forgotPasswordLink" href="/my-account/forgot.php?continue_to=%2F%2Fwww.zacks.com%2Fcommentary.php%3Farticle_id%3D2367142%26type%3Dcommentary%26cid%3DCS-MSN-FT-zacks_1_rank_additions-2367142">Don't Know Your Password?</a></p>
<p><input class="fancy_button green" type="submit" value="Sign In"/></p>
<button aria-label="Close" role="button" tabindex="0" type="button">
<span id="mob_close_login">Close this window</span>
</button>
</form>
</div>
<!-- End: Login form -->
</li></ul>
</div>
<div class="mobile_menu_trigger">
<button class="mobile_toggle">Menu</button>
</div>
</div>
<div class="header-bottom" id="header-bottom">
<!-- search goes here -->
<div class="relocated_searchbox">
<form action="/search.php" autocomplete="off" id="search_form" method="post" name="frmsearch">
<label class="sr-only" for="search-q" id="header_search">Quote or Search</label>
<input aria-autocomplete="both" aria-controls="result_list_view" aria-expanded="false" aria-haspopup="listbox" autofocus="autofocus" class="dropdown" hasdefault="false" id="search-q" name="search-q" placeholder="Quote or Search" searchextras="all" type="search" value="">
<button type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
<span class="sr-only">Search</span>
</button>
<input class="search_mode" name="search_mode" type="hidden" value="">
<input class="ticker_type" name="ticker_type" type="hidden" value="">
<div class="result_container" id="result_list_view">
<div class="results_tickers"></div>
</div>
</input></input></input></form>
</div>

</div>
</div>
</header>
<div class="mobile-menu-close-container">
<button class="mobile-menu-close">
<span class="icon close" role="img">
<?xml version="1.0" ?><svg viewbox="0 0 32 32" xmlns="http://www.w3.org/2000/svg"><defs></defs><title></title><g id="cross"><line class="cls-1" x1="7" x2="25" y1="7" y2="25"></line><line class="cls-1" x1="7" x2="25" y1="25" y2="7"></line></g></svg>
</span>
</button>
</div>
<div class="mobile_menu">
<div class="mobile_menu_header">
<a class="logo_link" href="/">
<img alt="Zacks" src="https://staticx.zacks.com/images/zacks/logos/zacks_logo_200x57.png"/>
</a>
</div>
<div class="mobile-menu-content">
<ul>
<li><a class="mobile_menu_link" href="//www.zacks.com">Home</a></li>
<li class="menu-items"><button class="mobile_menu_link">
<span class="menu_name">Stocks</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_2" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_2" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Stocks</span>
</button>
</div> <ul><li><a href="//www.zacks.com/stocks.php">Stocks</a></li>
<li><a href="//www.zacks.com/stocks/buy-list/?adid=zp_topnav_1list">Zacks #1 Rank</a></li>
<li><a href="//www.zacks.com/stocks/zacks-rank">Zacks Rank</a></li>
<li><a href="//www.zacks.com/stocks/industry-rank/industries/">Zacks Industry Rank</a></li>
<li><a href="//www.zacks.com/stocks/industry-rank/sectors/">Zacks Sector Rank</a></li>
<li><a href="//www.zacks.com/stocks/equity-research">Equity Research</a></li>
<li><a href="//www.zacks.com/stock-market-today">Markets</a></li>
</ul></div></li>
<li class="menu-items"><button class="mobile_menu_link">
<span class="menu_name">Funds</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_3" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_3" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Funds</span>
</button>
</div> <ul><li><a href="//www.zacks.com/funds/">Funds</a></li>
<li><a href="//www.zacks.com/funds/mutual-funds">Mutual Funds</a></li>
<li><a href="//www.zacks.com/funds/etfs">ETFs</a></li>
<li><a href="//www.zacks.com/screening/mutual-fund-screener">Mutual Fund Screener</a></li>
<li><a href="//www.zacks.com/screening/etf-screener">ETF Screener</a></li>
<li><a href="//www.zacks.com/funds/top-etfs">Top ETFs</a></li>
</ul></div></li>
<li><a class="mobile_menu_link" href="//www.zacks.com/cryptocurrency">Crypto</a></li>
<li class="menu-items"><button class="mobile_menu_link">
<span class="menu_name">Earnings</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_5" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_5" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Earnings</span>
</button>
</div> <ul><li><a href="//www.zacks.com/earnings">Earnings</a></li>
<li><a href="//www.zacks.com/earnings/earnings-calendar">Earnings Calendar</a></li>
<li><a href="//www.zacks.com/earnings/earnings-reports">Earnings Releases</a></li>
<li><a href="//www.zacks.com/earnings/earnings-surprise-predictions/">Earnings ESP</a></li>
<li><a href="//www.zacks.com/premium/esp-buy?adid=zp_topnav_espfilter">Earnings ESP Filter</a></li>
</ul></div></li>
<li class="menu-items"><button class="mobile_menu_link">
<span class="menu_name">Screening</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_6" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_6" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Screening</span>
</button>
</div> <ul><li><a href="//www.zacks.com/screening">Screening</a></li>
<li><a href="//www.zacks.com/screening/stock-screener">Stock Screener</a></li>
<li><a href="//www.zacks.com/screening/mutual-fund-screener">Mutual Fund Screener</a></li>
<li><a href="//www.zacks.com/screening/etf-screener">ETF Screener</a></li>
<li><a href="//www.zacks.com/screening/premium-screens">Premium Screens</a></li>
<li><a href="//www.zacks.com/screening/basic-screens/">Basic Screens</a></li>
<li><a href="//www.zacks.com/screening/thematic-screens/">Thematic Screens</a></li>
<li><a href="//www.zacks.com/researchwizard/index.php?site=screen">Research Wizard</a></li>
</ul></div></li>
<li class="menu-items"><button class="mobile_menu_link">
<span class="menu_name">Finance</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_7" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_7" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Finance</span>
</button>
</div> <ul><li><a href="//www.zacks.com/finance/">Personal Finance</a></li>
<li><a href="//www.zacks.com/personal-finance/583/Money-Management">Money Management</a></li>
<li><a href="//www.zacks.com/personal-finance/585/Retirement-Planning">Retirement Planning</a></li>
<li><a href="//www.zacks.com/personal-finance/586/Tax-Information">Tax Information</a></li>
</ul></div></li>
<li class="menu-items"><button class="mobile_menu_link">
<span class="menu_name">Portfolio</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_8" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_8" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Portfolio</span>
</button>
</div> <ul><li><a href="//www.zacks.com/portfolios/my-stock-portfolio/">My Portfolio</a></li>
<li><a href="/portfolios/my-stock-portfolio?mode=create-new-portfolio">Create Portfolio</a></li>
</ul></div></li>
<li class="menu-items"><button class="mobile_menu_link">
<span class="menu_name">Education</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_9" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_9" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Education</span>
</button>
</div> <ul><li><a href="//www.zacks.com/education/stock-education">Stocks</a></li>
<li><a href="//www.zacks.com/style-scores-education/">Style Scores</a></li>
<li><a href="//www.zacks.com/education/mutual-fund-education">Funds</a></li>
<li><a href="//www.zacks.com/education/esp-education/">Earnings ESP</a></li>
<li><a href="//www.zacks.com/education/screening-education">Screening</a></li>
<li><a href="//www.zacks.com/reviews">Testimonials</a></li>
<li><a href="//www.zacks.com/start-here">Zacks.com Tutorial</a></li>
</ul></div></li>
<li><a class="mobile_menu_link" href="//www.zacks.com/financial-videos/index.php">Video</a></li>
<li><a class="mobile_menu_link" href="//www.zacks.com/podcasts/">Podcasts</a></li>
<li class="menu-items orange">
<button class="mobile_menu_link">
<span class="menu_name">Services</span>
<span class="icon arrow" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_12" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="160,115.4 180.7,96 352,256 180.7,416 160,396.7 310.5,256 "></polygon></svg>
</span>
</button>
<div class="mobile-menu-sub-section">
<div class="mobile_menu_header">
<button class="mobile_menu_sub_section_close">
<span class="icon arrow-left" role="img">
<?xml version="1.0" ?><!DOCTYPE svg  PUBLIC '-//W3C//DTD SVG 1.1//EN'  'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'>
<svg height="512px" id="Layer_12" style="enable-background:new 0 0 512 512;" version="1.1" viewbox="0 0 512 512" width="512px" xml:space="preserve" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><polygon points="352,115.4 331.3,96 160,256 331.3,416 352,396.7 201.5,256 "></polygon></svg>
</span>
<span class="menu-title">Services</span>
</button>
</div>
<div class="services-menu-content"> <h3>
<span class="menu_name">Services Overview</span>
</h3>
<ul>
<li><a href="//www.zacks.com/ultimate/?adid=TOP_ONLINE_NAV">Zacks Ultimate</a></li>
<li><a href="//www.zacks.com/investorcollection/">Zacks Investor Collection</a></li>
<li><a href="//www.zacks.com/premium.php">Zacks Premium</a></li>
</ul>
<h3>
<span class="menu_name">Investor Services</span>
</h3>
<ul>
<li><a href="//www.zacks.com/etfinvestor/">ETF Investor</a></li>
<li><a href="//www.zacks.com/homerun/?adid=TOP_ONLINE_NAV">Home Run Investor</a></li>
<li><a href="//www.zacks.com/incomeinvestor/">Income Investor</a></li>
<li><a href="//www.zacks.com/stocksunder10/">Stocks Under $10</a></li>
<li><a href="//www.zacks.com/valueinvestor/?adid=TOP_ONLINE_NAV">Value Investor</a></li>
<li><a href="//www.zacks.com/top-10-stocks.php">Top 10 Stocks</a></li>
</ul>
<h3>
<span class="menu_name">Other Services</span>
</h3>
<ul>
<li><a href="//www.zacks.com/registration/zmt/welcome/eoffer/33e3/?adid=TOP_ONLINE_NAV">Method for Trading</a></li>
<li><a href="//www.zacks.com/registration/rw/welcome/eoffer/3dd7/?adid=TOP_ONLINE_NAV">Research Wizard</a></li>
<li><a href="//www.zacks.com/confidential/?adid=TOP_ONLINE_NAV">Zacks Confidential</a></li>
</ul>
<h3>
<span class="menu_name">Trading Services</span>
</h3>
<ul>
<li><a href="//www.zacks.com/blackboxtrader/">Black Box Trader</a></li>
<li><a href="//www.zacks.com/counterstrike/">Counterstrike</a></li>
<li><a href="//www.zacks.com/headlinetrader/">Headline Trader</a></li>
<li><a href="//www.zacks.com/insidertrader/">Insider Trader</a></li>
<li><a href="//www.zacks.com/largecaptrader/">Large-Cap Trader</a></li>
<li><a href="//www.zacks.com/optionstrader/">Options Trader</a></li>
<li><a href="//www.zacks.com/shortlist/">Short Sell List</a></li>
<li><a href="//www.zacks.com/surprisetrader/">Surprise Trader</a></li>
<li><a href="//www.zacks.com/tazr/">TAZR</a></li>
</ul>
<h3>
<span class="menu_name">Innovators</span>
</h3>
<ul>
<li><a href="//www.zacks.com/alternativeenergyinnovators/">Alternative Energy</a></li>
<li><a href="//www.zacks.com/blockchaininnovators/">Blockchain</a></li>
<li><a href="//www.zacks.com/commodityinnovators/">Commodity</a></li>
<li><a href="//www.zacks.com/healthcareinnovators/">Healthcare</a></li>
<li><a href="//www.zacks.com/marijuanainnovators/">Marijuana</a></li>
<li><a href="//www.zacks.com/technologyinnovators/">Technology</a></li>
</ul>
</div></div></li>
</ul>
</div>
</div>
</div> <!-- Begin: Header Ad -->
<div id="banner" role="banner">
<a href="/" rel="home" role="link">
<img alt="Zacks Investment Research Home" height="92" src="https://staticx.zacks.com/images/zacks/logos/logo2014_tagstack-sitehead_232x92_2x.png" title="" width="232"></img></a>
<!-- nav toggle button for mobile menu -->
<div class="nav-toggle">
<span></span>
<span></span>
<span></span>
</div>
<!-- nav toggle button for mobile menu --><!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_728x90_1"></div><!-- investing channel adcode -->
<div class="dfp_ad_unit" id="IC_M_320x50_1"></div> </div>
<!-- End: Header Ad -->
<div class="hide" id="gateway_modal_offsite">
<p>You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.</p>
<p>If you wish to go to ZacksTrade, click <strong>OK</strong>. If you do not, click Cancel.</p>
<p class="zt_offsite_button"><a class="fancy_button green" href="{https://www.zackstrade.com/2019-1-dollar}" id="gateway_offsite_link">OK</a> <a class="fancy_button deactive" href="#">Cancel</a></p>
</div>
<!-- z2_top_nav end -->
<!-- End: top_navigation-->
<!-- Begin: Main Content -->
<div id="main_content" role="main">
<!-- Begin: toolbar-->
<!-- z2_toolbar start -->
<div id="toolbar">
<span>Back to top</span>
</div>
<!-- z2_toolbar end -->
<!-- End: toolbar-->
<div class="main_body">
<!-- Begin: centerCol -->
<!-- z2_commentary_using_view start -->
<section class="commentary_b" id="commentary_article">



<div class="article_banner">
<img alt="" ll_src="https://staticx-tuner.zacks.com/images/articles/main/ab/2180.jpg" src="https://staticx.zacks.com/images/icons/general/trans.png" title=""/>
<p>Image: Bigstock</p>
</div>
<article>
<h1>Pharma Stock Roundup: ABBV, LLY Coronavirus Product Development Efforts, FDA Updates</h1>
<header class="ticker-and-social-ribbon">
<aside>
<p class="byline">Kinjel Shah
                    <span><time datetime="00:00">March 13, 2020</time></span>
</p>
<p class="hoverquote_block"><button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="AZN">AZN Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/AZN" id="ticker_social_ribbon-AZN-txt" rel="AZN" show-add-portfolio="true"><span class="hoverquote-symbol">AZN</span></a> <button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="RHHBY">RHHBY Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-neg" href="/stock/quote/RHHBY" id="ticker_social_ribbon-RHHBY-txt" rel="RHHBY" show-add-portfolio="true"><span class="hoverquote-symbol">RHHBY</span></a> <button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="BMY">BMY Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/BMY" id="ticker_social_ribbon-BMY-txt" rel="BMY" show-add-portfolio="true"><span class="hoverquote-symbol">BMY</span></a> <button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="JNJ">JNJ Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/JNJ" id="ticker_social_ribbon-JNJ-txt" rel="JNJ" show-add-portfolio="true"><span class="hoverquote-symbol">JNJ</span></a> <button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="MRK">MRK Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/MRK" id="ticker_social_ribbon-MRK-txt" rel="MRK" show-add-portfolio="true"><span class="hoverquote-symbol">MRK</span></a> <button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="LLY">LLY Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-neg" href="/stock/quote/LLY" id="ticker_social_ribbon-LLY-txt" rel="LLY" show-add-portfolio="true"><span class="hoverquote-symbol">LLY</span></a> <button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="ABBV">ABBV Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/ABBV" id="ticker_social_ribbon-ABBV-txt" rel="ABBV" show-add-portfolio="true"><span class="hoverquote-symbol">ABBV</span></a> </p>

<p>
<a class="zt_offsite_link" id="ztBtn_better_commentary" tracking_code="13418215">
<img border="0" class="valign" height="20" src="https://staticx-tuner.zacks.com/woas/adv/ztrade/zt-icon.png" style="margin:0 !important;" width="23">
<span class="valign" style="top:2px;">Better trading starts <em style="border-bottom:solid 1pt #2C2C2C;">here.</em></span>
</img></a>
</p>
<!--MSG:16163, content.zacks.com, bottom STAGE/PRODUCTION textarea-->
<div>
<div class="social_plugins">
<div class="social_icons_left">


<a href="/registration/author_email/?mode=follow&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-follow-ticker_social_ribbon-button&amp;author_id=486881667&amp;continue_to=%252F%252Fwww.zacks.com%252Fcommentary.php%253Farticle_id%253D811614%2526type%253Dblog%26type%3Dblog%26ADID%3DFOL_AUT"><img alt="Follow" author="" class="small_follow_btn" height="28" src="https://staticx.zacks.com/images/zacks/icons/mobile_follow_btn.png" title="Follow Author" width="80"/></a>
<span class="st_facebook_large" displaytext="Facebook" st_url="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates?cid=SM-facebook-HL-811614"></span>
<span class="st_twitter_large" displaytext="Tweet" st_url="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates?cid=SM-twitter-HL-811614"></span>
<span class="st_linkedin_large" displaytext="LinkedIn" st_url="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates?cid=SM-linkedin-HL-811614"></span>
<span class="st_pinterest_large" displaytext="Pinterest" st_url="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates?cid=SM-pinterest-HL-811614"></span>
<span class="st_email_large" displaytext="Email" st_url="https://www.zacks.com/stock/news/811614/pharma-stock-roundup-abbv-lly-coronavirus-product-development-efforts-fda-updates?cid=SM-email-HL-811614"></span>
</div> <div class="social_icons_right">
<a class="stocktwits-button" data-article-id="811614" href="https://api.stocktwits.com/widgets/share" id="stocktwits-share-button-view"><img alt="Share on StockTwits" src="https://staticx.zacks.com/images/zacks/icons/st_icon.png"/></a>

</div>
</div>
</div>
<!-- edit follow section-->
<div class="edit_follow_section">
<p id="category_part" style="display:none">
<span>You follow Analyst Blog - <a class="call_action" href="/my-account/alert-preferences/">edit</a></span>
</p>
<p id="author_part" style="display:none">
<span>You follow Kinjel Shah - <a class="call_action" href="/my-account/alert-preferences/">edit</a></span>
</p>
</div>
<!-- follow author modal-->
<div class="author_modal" id="follow_author_toggle">
<h4>What would you like to follow?</h4>
<div class="container">
<input id="is_follow_category" name="is_follow_category" type="hidden" value="Y">
<input id="is_follow_author" name="is_follow_author" type="hidden" value="N">
<p id="author_follow_button" style="display:none">
<input id="modal_author_name" name="modal_author_name" type="checkbox" value="486881667"/>
<label for="modal_author_name">Kinjel Shah</label>
</p>
<p id="category_follow_button" style="display:block">
<input id="modal_article_category" name="modal_article_category" type="checkbox" value="213"/>
<label for="modal_article_category">Analyst Blog</label>
</p>
<div class="buttons">
<a class="modal_external" href="/modals/follow-author.php?author_id=NULL&amp;category_id=NULL" id="follow_action" title="">
<img alt="Follow Author" class="small_follow_btn" src="https://staticx.zacks.com/images/zacks/icons/mobile_follow_btn.png" title=""/>
</a>
<a class="cancel" onclick="document.getElementById('follow_author_toggle').style.display='none'">Cancel</a>
</div>
</input></input></div>
</div>
</aside>
</header>
</article> <article>
<div class="archive_collapse"><span class="show_article">Read More</span><span class="hide_article">Hide Full Article</span></div>
<div class="commentary_body">
<div id="inline_top">
<!-- investing channel adcode -->
<div class="dfp_ad_unit" id="IC_M_3x7_1"></div>
</div>
<div id="comtext">
<p style="text-align: justify;">This week Lilly (<button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="LLY">LLY Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-neg" href="/stock/quote/LLY" id="commentary_body-LLY-txt" rel="LLY" show-add-portfolio="true" style="font-weight:bold;"><span class="hoverquote-symbol">LLY</span></a> <span>-</span> <a alt="Free Report" class="in_copy newwin" href="/registration/premium/login/?ALERT=zrmodule&amp;mode=zramodule&amp;t=LLY&amp;ADID=ZCOM_ARTICLEBODY_TCK_ANALYSTBLOG_213_811614_LLY&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_body-text-LLY" title="Free Report">Free Report</a>)     signed a deal to co-develop antibody therapies with private biotech, AbCellera to treat and prevent coronavirus disease, COVID-19. AbbVie (<button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="ABBV">ABBV Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/ABBV" id="commentary_body-ABBV-txt" rel="ABBV" show-add-portfolio="true" style="font-weight:bold;"><span class="hoverquote-symbol">ABBV</span></a> <span>-</span> <a alt="Free Report" class="in_copy newwin" href="/registration/premium/login/?ALERT=zrmodule&amp;mode=zramodule&amp;t=ABBV&amp;ADID=ZCOM_ARTICLEBODY_TCK_ANALYSTBLOG_213_811614_ABBV&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_body-text-ABBV" title="Free Report">Free Report</a>)     informed that it is collaborating with European &amp; U.S. health authorities to back studies on its HIV medicine Kaletra for treating COVID-19. Bristol-Myers (<button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="BMY">BMY Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/BMY" id="commentary_body-BMY-txt" rel="BMY" show-add-portfolio="true" style="font-weight:bold;"><span class="hoverquote-symbol">BMY</span></a> <span>-</span> <a alt="Free Report" class="in_copy newwin" href="/registration/premium/login/?ALERT=zrmodule&amp;mode=zramodule&amp;t=BMY&amp;ADID=ZCOM_ARTICLEBODY_TCK_ANALYSTBLOG_213_811614_BMY&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_body-text-BMY" title="Free Report">Free Report</a>)     immunotherapy combo, Opdivo + Yervoy was approved by the FDA for previously treated hepatocellular carcinoma, the most common form of liver cancer.</p><p style="text-align: justify;"><strong>Recap of the Weekâs Most Important Stories:</strong></p><p style="text-align: justify;"><strong><em>AbbVie, Roche &amp; Lillyâs Coronavirus Updates:</em></strong>Lilly announced a collaboration deal with private biotech, AbCellera to co-develop antibody therapies to treat and prevent COVID-19. To develop these therapies, the companies will select from more than 500 unique antibodies identified by AbCellera and isolated from the blood sample of a U.S. COVID-19 patient who recovered from the disease. The companies will equally share initial development costs for the antibody products after which Lilly will take care of further development, manufacturing and distribution.</p><p style="text-align: justify;">AbbVie is working with global health authorities to determine the efficacy of its HIV medicine, <a href="https://www.zacks.com/stock/news/807816/abbvie-backs-studies-on-hiv-drug-kaletra-for-coronavirus-cure?art_rec=quote-stock_overview-zacks_news-ID02-txt-807816">Kaletra/</a>Aluvia against coronavirus disease. The company said it is coordinating with European and U.S. health authorities to support clinical studies on Kaletra/Aluvia for COVID-19 treatment. Kaletra/Aluvia is a combination of lopinavir and ritonavir.</p><p style="text-align: justify;">Roche (<button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="RHHBY">RHHBY Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-neg" href="/stock/quote/RHHBY" id="commentary_body-RHHBY-txt" rel="RHHBY" show-add-portfolio="true" style="font-weight:bold;"><span class="hoverquote-symbol">RHHBY</span></a> <span>-</span> <a alt="Free Report" class="in_copy newwin" href="/registration/premium/login/?ALERT=zrmodule&amp;mode=zramodule&amp;t=RHHBY&amp;ADID=ZCOM_ARTICLEBODY_TCK_ANALYSTBLOG_213_811614_RHHBY&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_body-text-RHHBY" title="Free Report">Free Report</a>)     announced that the FDA has granted Emergency Use Authorization (EUA) to its cobas SARS-CoV-2 test to detect virus that causes COVID-19. The test, which has not yet been approved by the FDA, can be performed on Rocheâs cobas 6800/8800 systems. The test is available in markets that accept the CE mark and in areas where the SARS-CoV-2 virus is confirmed to be present. Several other biotech/drug companies are working on making treatments/vaccines to treat COVID-19.</p><p style="text-align: justify;"><strong><em>Bristol-Myers Opdivo + Yervoy Combo Gets FDA Nod for Liver Cancer:</em></strong> The FDA granted accelerated approval to Bristol-Myersâs dual immunotherapy - <a href="https://www.zacks.com/stock/news/809561/bristol-myers-opdivo-yervoy-combo-gets-fda-nod-for-hcc?art_rec=quote-stock_overview-zacks_news-ID01-txt-809561">Opdivo + Yervoy</a>- for patients with hepatocellular carcinoma (HCC) previously treated with Bayerâs Nexavar (sorafenib). The approval was based on data from the CheckMate -040 study in which Opdivo + Yervoy showed an overall response rate of 33%. With approval for this most common and aggressive form of liver cancer, the Opdivo + Yervoy combination is now approved to treatÂ  four types of cancer.</p><p style="text-align: justify;">Meanwhile, Bristol-Myersâ phase III study evaluating <a href="https://www.zacks.com/stock/news/805980/bristolmyers-empliciti-combo-fails-in-firstline-myeloma-study?art_rec=quote-stock_overview-zacks_news-ID01-txt-805980">Empliciti</a>plus Revlimid and dexamethasone (ERd) as a first-line treatment option for patients with multiple myeloma not eligible for transplantÂ failed to meet its primary endpoint. Data from the study showed that the ERd combo failed to demonstrate statistically significant improvement in progression-free-survival (PFS) compared to a combination of Revlimid and dexamethasone (Rd). The ERd combo is already approved for the treatment of relapsed and refractory multiple myeloma (r/rMM).</p><p style="text-align: justify;"><strong><em>AstraZeneca/Merckâs Ovarian Cancer Study on Lynparza Doublet Fails:</em></strong>AstraZeneca (<button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="AZN">AZN Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/AZN" id="commentary_body-AZN-txt" rel="AZN" show-add-portfolio="true" style="font-weight:bold;"><span class="hoverquote-symbol">AZN</span></a> <span>-</span> <a alt="Free Report" class="in_copy newwin" href="/registration/premium/login/?ALERT=zrmodule&amp;mode=zramodule&amp;t=AZN&amp;ADID=ZCOM_ARTICLEBODY_TCK_ANALYSTBLOG_213_811614_AZN&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_body-text-AZN" title="Free Report">Free Report</a>)     and Merckâs (<button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="MRK">MRK Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/MRK" id="commentary_body-MRK-txt" rel="MRK" show-add-portfolio="true" style="font-weight:bold;"><span class="hoverquote-symbol">MRK</span></a> <span>-</span> <a alt="Free Report" class="in_copy newwin" href="/registration/premium/login/?ALERT=zrmodule&amp;mode=zramodule&amp;t=MRK&amp;ADID=ZCOM_ARTICLEBODY_TCK_ANALYSTBLOG_213_811614_MRK&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_body-text-MRK" title="Free Report">Free Report</a>)     phase III study evaluating efficacy of a potential new medicine cediranib added to PARP inhibitor Lynparza did not meet the primary endpoint of PFS in patients with platinum-sensitive relapsed ovarian cancer.Â The GY004 study was led by NRG Oncology and sponsored by the U.S. National Cancer Institute (NCI) and evaluated cediranib plus Lynparza versus platinum-based chemotherapy</p><p style="text-align: justify;"><strong><em>AbbVie/Roche Get EU Nod for Venclexta+Gazyva in First-Line CLL</em></strong>: The European Commission approved a combination of AbbVie/Rocheâs Venclyxto (called Venclexta in United States) and Rocheâs Gazyva as a fixed duration treatment for first-line chronic lymphocytic leukemia (CLL). The approval was based on data from the phase III CLL14 study. The approval was expected as the CHMP had given a positive opinion recommending approval of the combination in January. The combination was approved for the same indication by the FDA in May last year.</p><p style="text-align: justify;"><strong><em>FDAâs Breakthrough Tag for J&amp;Jâs Lung Cancer Candidate:</em></strong>The FDA granted Breakthrough Therapy status to J&amp;Jâs (<button class="modal_external appear-on-focus" href="/modals/quick-quote.php" rel="JNJ">JNJ Quick Quote</button><a class="hoverquote-container-od analytics_tracking hoverquote-pos" href="/stock/quote/JNJ" id="commentary_body-JNJ-txt" rel="JNJ" show-add-portfolio="true" style="font-weight:bold;"><span class="hoverquote-symbol">JNJ</span></a> <span>-</span> <a alt="Free Report" class="in_copy newwin" href="/registration/premium/login/?ALERT=zrmodule&amp;mode=zramodule&amp;t=JNJ&amp;ADID=ZCOM_ARTICLEBODY_TCK_ANALYSTBLOG_213_811614_JNJ&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_body-text-JNJ" title="Free Report">Free Report</a>)     JNJ-6372, a dual-targeting EGFR-MET bispecific antibody, for the treatement of non-small cell lung cancer (NSCLC) in patients with EGFR Exon 20 insertion mutations. The designation was based on data from a phase I study evaluating the candidate in adult patients with advanced NSCLC.</p><p style="text-align: justify;">Meanwhile, the FDA granted Fast Track designation to Lillyâs diabetes medicine Jardiance to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease. Jardiance is being evaluated in the EMPA-KIDNEY clinical study in the above patient population with or without diabetes.</p><p style="text-align: justify;">The NYSE ARCA Pharmaceutical Index declined 12.89% in the last five trading sessions.</p><div class="chart_embed"><p><strong>Large Cap Pharmaceuticals Industry 5YR % Return</strong></p><a href="https://www.zacks.com/stocks/industry-rank/industry/large-cap-pharmaceuticals-126?icid=chart-large-cap-pharmaceuticals-industry-5yr-return"> <img alt="Large Cap Pharmaceuticals Industry 5YR % Return" src="https://staticx-tuner.zacks.com/images/charts/04/1584095741.png" title=""/> </a><p><a href="https://www.zacks.com/stocks/industry-rank/industry/large-cap-pharmaceuticals-126?icid=chart-large-cap-pharmaceuticals-industry-5yr-return">Large Cap Pharmaceuticals Industry 5YR % Return</a></p></div><p>Here is how the seven major stocks performed in the last five trading sessions.</p><p style="text-align: justify;"><img alt="" src="https://staticx-tuner.zacks.com/images/zadmin_tuner_image/price%20chart%203-13-2020.jpg"/></p><p style="text-align: justify;">Last week, all the stocks were in the red with AstraZeneca declining the most (15.8%).</p><p style="text-align: justify;">In the past six months, Lilly has risen the most (14.4%) while Pfizer declined the most (18.5%).</p><p style="text-align: justify;">(See the last pharma stock roundup here: <a href="https://www.zacks.com/stock/news/799956/pharma-stock-roundup-trump-pharma-executives-meeting-on-coronavirus-fda-updates">Trump, Pharma Executives Meeting on Coronavirus, FDA Updates</a>)</p><p style="text-align: justify;"><strong>What's Next in the Pharma World?</strong></p><p style="text-align: justify;">Watch out for regular pipeline and regulatory updates next week.</p><p style="text-align: justify;"><strong>Zacks Top 10 Stocks for 2020</strong></p><p style="text-align: justify;">In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?</p><p style="text-align: justify;">Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Donât miss your chance to get in on these long-term buys.</p><p style="text-align: justify;"><a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/2beb?adid=ZCOM_ZU_TOP10A_INVESTIDEAS_IND_T10A_031320&amp;icid=EOAC-INVESTIDEAS-tx-ZU031320">Access Zacks Top 10 Stocks for 2020 today &gt;&gt;</a></p><div class="cta_section"></div>
</div>
<div id="inline_bottom">
<!-- investing channel adcode -->
<div class="dfp_ad_unit" id="IC_M_3x7_2"></div>
</div>
<div id="third_para_ad">
<!-- investing channel desktop adcode -->
<div class="dfp_ad_unit" id="IC_d_div_3x7_1"></div>
</div>
</div>
</article>
</section> <section class="commentary_reports_content commentary_b ab_reports">
<div class="commentary_reports">
<div class="commentary_reports_block">
<br/><div class="reports_header"><h1>Zacks' 7 Best Strong Buy Stocks (New Research Report)</h1><br/></div>
<div class="article"><p>Valued at $99, click below to receive our just-released report<br>predicting the 7 stocks that will soar highest in the coming month.</br></p><br/></div>
<p class=""><a class="input_button" href="/registration/premium/login/?ALERT=RPT_7BST_LP194&amp;mode=split_test&amp;t=AZN&amp;ADID=ZCOM_ARTICLEBTM_7BEST_ANBLTEST15_ANALYSTBLOG_213_811614_AZN&amp;icid=BLOG-Analyst_Blog|Stock_Roundup-811614-free_report-commentary_reports-text-AZN" target="_blank"><span aria-hidden="true">â¸</span> Click Here, It's Really Free</a></p>
</div>
</div>
</section>







<!-- z2_commentary_using_view end -->
<!-- z2_more_from_zacks_category start -->
<section class="commentary_zacks_news commentary_grid_container" id="z2_more_from_zacks_category"></section>

<!-- z2_more_from_zacks_category end -->
<!-- z2_you_may_like start -->
<section class="commentary_zacks_news commentary_grid_container you_may_like" id="youmay_like_container"></section>

<!-- z2_you_may_like end -->
<!-- z2_published_in start -->
<section class="" id="">
<h1>Published in</h1> <a class="text_capitalize article_tag" href="/topics/pharmaceuticals" title="pharmaceuticals">pharmaceuticals</a>
</section><!-- z2_published_in end -->
<!-- End: centerCol -->
</div> <!-- End: Main Body -->
<aside id="third_rail">
<!-- Begin: rightCol -->
<!-- right_panel start -->
<!-- In Your face Start -->
<div id="featured_zacks_rank_stocks">
<div id="slider">
<!-- Commentary IYF Module B - #671 -->

<section id="commentary-module">
<h1 class="headline">Zacks' 7 Best<br>Strong Buy Stocks for November, 2024</br></h1>
<p>Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next 30-90 days.</p>
<p>Recent stocks from this report have soared up to +67.5% within 30 days - this month's picks could be even better. See our report's fresh new picks today - it's really free!</p>
<form action="/registration/pfp/step2.php" id="iyfModuleForm" method="post" name="pfp-commentary-form" onsubmit="return false;"><input class="textbox" id="email" maxlength="200" name="email" onblur="this.placeholder='Enter your best email address'" onfocus="this.placeholder=''" placeholder="Enter your best email address" type="text"> <input name="ADID" type="hidden" value="ZCOM_IYFCOMM_7BEST_FRESH"> <input name="ALERT" type="hidden" value="IYF_COMM_671_A384"><button class="input_button submit submit-iyf" id="button">â¸ See Our 7 Strongest Buys Free</button></input></input></input></form>
<footer id="footer">
<p><a class="call_to_action newwin" href="/privacy.php">Privacy Policy</a> <span aria-hidden="true">|</span> No cost, no obligation to buy anything ever.<br>Past performance is no guarantee of future results.</br></p>
</footer>
</section>

</div>
</div>

<!-- In Your face End -->
<!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_300x250_1"></div> <!-- investing channel adcode -->
<div class="dfp_ad_unit" id="IC_M_3X3_1"></div>
<!-- Display this section only if data is being provided -->
<div class="next_news content_block">
<!-- Begin: Next news -->
<h1 class="side_bar_header">Up Next</h1>
<div class="next_media content_block">
<a href="/stock/news/811633/harley-davidson-down-44-in-a-year-will-the-bad-spell-stay?art_rec=blog-analyst_blog-up_next-ID01-img-811633">
<img alt="" ll_src="https://staticx-tuner.zacks.com/images/articles/main/db/726.jpg" src="https://staticx.zacks.com/images/icons/general/trans.png" title=""/></a>
<a href="/stock/news/811633/harley-davidson-down-44-in-a-year-will-the-bad-spell-stay?art_rec=blog-analyst_blog-up_next-ID01-txt-811633"><h2 class="side_bar_article_link">Harley-Davidson Down 44% in a Year: Will the Bad Spell Stay?</h2>
</a>
</div>
</div>
<!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_300x250_2"></div> <div class="read_articles content_block">
<!-- Begin: Read article section -->
<h1 class="side_bar_header">Most Read</h1>
<div id="slider_wrapper">
<div class="swiper-container_mostread swiper-container-horizontal">
<div class="swiper-wrapper">
<div class="swiper-slide swiper-slide-active" style="margin-right: 18px;">
<article>
<header class="article_track">
<div class="article_img"> <a class="analytics_tracking" href="https://www.zacks.com/stock/news/2371780/etf-industry-trends-and-the-post-election-outlook" id="most_read-2371780-img"><img alt="ETF Industry Trends and the Post-Election Outlook" height="60" ll_src="https://staticx-tuner.zacks.com/images/articles/specialcoverage/6f/70875.jpg" src="https://staticx.zacks.com/images/icons/general/trans.png" title="ETF Industry Trends and the Post-Election Outlook" width="100"/></a></div>
<h1 class="most_read_article teaser truncated_text_three"><div><a href="https://www.zacks.com/stock/news/2371780/etf-industry-trends-and-the-post-election-outlook" id="most_read-2371780-txt">ETF Industry Trends and the Post-Election Outlook</a></div></h1>
</header>
</article>
</div><div class="swiper-slide swiper-slide-active" style="margin-right: 18px;">
<article>
<header class="article_track">
<div class="article_img"> <a class="analytics_tracking" href="https://www.zacks.com/stock/news/2371776/top-stock-picks-for-week-of-november-18-2024" id="most_read-2371776-img"><img alt="Top Stock Picks for Week of November 18, 2024" height="60" ll_src="https://staticx-tuner.zacks.com/images/articles/specialcoverage/64/84733.jpg" src="https://staticx.zacks.com/images/icons/general/trans.png" title="Top Stock Picks for Week of November 18, 2024" width="100"/></a></div>
<h1 class="most_read_article teaser truncated_text_three"><div><a href="https://www.zacks.com/stock/news/2371776/top-stock-picks-for-week-of-november-18-2024" id="most_read-2371776-txt">Top Stock Picks for Week of November 18, 2024</a></div></h1>
</header>
</article>
</div><div class="swiper-slide swiper-slide-active" style="margin-right: 18px;">
<article>
<header class="article_track">
<div class="article_img"> <a class="analytics_tracking" href="https://www.zacks.com/stock/news/2371786/markets-mixed-monday-nvidia-forecast-and-more" id="most_read-2371786-img"><img alt="Markets Mixed Monday: NVIDIA Forecast and More" height="60" ll_src="https://staticx-tuner.zacks.com/images/articles/specialcoverage/69/71961.jpg" src="https://staticx.zacks.com/images/icons/general/trans.png" title="Markets Mixed Monday: NVIDIA Forecast and More" width="100"/></a></div>
<h1 class="most_read_article teaser truncated_text_three"><div><a href="https://www.zacks.com/stock/news/2371786/markets-mixed-monday-nvidia-forecast-and-more" id="most_read-2371786-txt">Markets Mixed Monday: NVIDIA Forecast and More</a></div></h1>
</header>
</article>
</div><div class="swiper-slide swiper-slide-active" style="margin-right: 18px;">
<article>
<header class="article_track">
<div class="article_img"> <a class="analytics_tracking" href="https://www.zacks.com/research-daily/2371401/top-analyst-reports-for-thermo-fisher-nextera-energy-lowes" id="most_read-2371401-img"><img alt="Top Analyst Reports for Thermo Fisher, NextEra Energy &amp; Lowe's" height="60" ll_src="https://staticx-tuner.zacks.com/images/articles/specialcoverage/58/467.jpg" src="https://staticx.zacks.com/images/icons/general/trans.png" title="Top Analyst Reports for Thermo Fisher, NextEra Energy &amp; Lowe's" width="100"/></a></div>
<h1 class="most_read_article teaser truncated_text_three"><div><a href="https://www.zacks.com/research-daily/2371401/top-analyst-reports-for-thermo-fisher-nextera-energy-lowes" id="most_read-2371401-txt">Top Analyst Reports for Thermo Fisher, NextEra Energy &amp; Lowe's</a></div></h1>
</header>
</article>
</div><div class="swiper-slide swiper-slide-active" style="margin-right: 18px;">
<article>
<header class="article_track">
<div class="article_img"> <a class="analytics_tracking" href="https://www.zacks.com/commentary/2371768/momentum-alert-top-financial-stocks-soar-pfsi-ntrs" id="most_read-2371768-img"><img alt="Momentum Alert: Top Financial Stocks Soar (PFSI, NTRS)" height="60" ll_src="https://staticx-tuner.zacks.com/images/articles/specialcoverage/e7/2427.jpg" src="https://staticx.zacks.com/images/icons/general/trans.png" title="Momentum Alert: Top Financial Stocks Soar (PFSI, NTRS)" width="100"/></a></div>
<h1 class="most_read_article teaser truncated_text_three"><div><a href="https://www.zacks.com/commentary/2371768/momentum-alert-top-financial-stocks-soar-pfsi-ntrs" id="most_read-2371768-txt">Momentum Alert: Top Financial Stocks Soar (PFSI, NTRS)</a></div></h1>
</header>
</article>
</div>
</div>
<!-- Add Pagination -->
<div class="swiper-pagination"></div>
<!-- Add Arrows -->
<div class="swiper-button-next" id="swiper-mostread-button-next">âº</div>
<div class="swiper-button-prev swiper-button-disabled" id="swiper-mostread-button-prev">â¹</div>
</div>
</div>
</div> <!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_300x125_1"></div> <!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_300x250_3"></div><!-- right_panel end -->
<!-- End: rightCol -->
</aside>
<!-- Begin: Bottom Ad -->
<!-- Begin: partnerDart -->
<!-- z2_comm_banner_bottom start -->
<!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_728x90_2"></div><!-- investing channel adcode -->
<div class="dfp_ad_unit" id="ic_d_div_1x1_1"></div><!-- z2_comm_banner_bottom end -->
<!-- End: partnerDart -->
<!-- End: Bottom Ad -->
</div> <!-- End: Main Content -->
<footer>
<!-- Begin: Footer -->
<!-- z2_footer start -->
<div id="quick_links">
<section>
<h2>Quick Links</h2>
<!-- nav toggle button for mobile menu -->
<div class="quicklink-toggle"><small></small> <small></small> <small></small></div>
<!-- nav toggle button for quick links for mobile -->
<div class="footer-links"><!-- Services -->
<div id="services">
<h3>Services</h3>
<nav>
<ul>
<li><a href="/investment-services/">Account Types</a></li>
<li><a href="/investment-services/">Premium Services</a></li>
<li><a href="/stocks/zacks-rank">Zacks Rank</a></li>
<li><a href="/stocks/">Research</a></li>
<li><a href="/finance/">Personal Finance</a></li>
<li><a href="/articles/">Commentary</a></li>
<li><a href="/stock-education.php">Education</a></li>
<li><a href="https://advisortools.zacks.com/">Zacks Advisor Tools</a></li>
</ul>
</nav>
</div>
<!-- My Account -->
<div id="my_account">
<h3>My Account</h3>
<nav>
<ul>
<li><a href="/my-account/index.php">Manage Account</a></li>
<li><a href="/my-account/login-info.php">Update Profile</a></li>
<li><a href="/my_account/order_history.php">Subscriptions</a></li>
<li><a href="/my-account/order/">Cancel Subscription</a></li>
<li><a href="/my-account/my-email.php">Preferences</a></li>
<li><a href="/my-account/alert-preferences/">Unsubscribe</a></li>
<li><a href="/help/faq.php#s12">Login/Password Help</a></li>
<li class="upgrade_premium_icid"><a href="/registration/premium/login/?continue_to=/registration/premium/trial/&amp;adid=zp_quicklinks_upgrade">Upgrade to Premium</a></li>
</ul>
</nav>
</div>
<!-- Resources -->
<div id="resources">
<h3>Resources</h3>
<nav>
<ul>
<li><a href="/help/">Help</a></li>
<li><a href="/about-zacks.php">About Zacks</a></li>
<li><a href="/bio/zacks-writers">Zacks Writers</a></li>
<li><a href="/privacy.php">Privacy Policy</a></li>
<li><a href="/registration/premium/welcome/eoffer/4f9f">Do Not Sell My Personal Information</a></li>
<li><a href="/terms_of_service">Terms of Service</a></li>
<li><a href="/performance_disclosure">Performance Disclosure</a></li>
<li><a href="/accessibility-statement">Accessibility</a></li>
<li><a href="/sitemap.php">Site Map</a></li>
<li><a href="/podcasts?ADID=podcast_landingpage">Podcasts</a></li>
<li><a href="/earnings/earnings-calendar">Earnings Calendar</a></li>
</ul>
</nav>
</div>
<!-- Client Support -->
<div id="client_support">
<h3>Client Support</h3>
<nav>
<ul>
<li><a href="/contact">Contact Us</a></li>
<li><a href="mailto:support@zacks.com">Share Feedback</a></li>
<li><a href="/media-room/">Media</a></li>
<li><a href="/careers.php">Careers</a></li>
<li><a href="/advertising">Advertise</a></li>
<li><a href="/reviews">Testimonials</a></li>
</ul>
</nav>
</div>
<!-- Follow Us -->
<div id="follow_us">
<h3>Follow Us</h3>
<nav>
<ul>
<li id="facebook"><a href="https://www.facebook.com/ZacksInvestmentResearch">Facebook</a></li>
<li id="twitter"><a href="https://twitter.com/ZacksResearch">Twitter</a></li>
<li id="linkedin"><a href="https://www.linkedin.com">Linkedin</a></li>
<li id="youtube"><a href="https://www.youtube.com/user/ZacksInvestmentNews">You Tube</a></li>
</ul>
</nav>
</div>
<!-- Zacks Moblie App -->
<div id="zacks_mobile_app">
<h3>Zacks Mobile App</h3>
<nav>
<ul>
<li id="apple_store"><a href="https://itunes.apple.com/us/app/zacks/id731593509?mt=8" title="Download our Zacks App from the Apple App Store"><img alt="Download our Zacks App from the Apple App Store" height="50" src="https://staticx.zacks.com/images/zacks/logos/app_Store_Badge_US-UK_RGB_blk_092917.svg" width="135"/></a></li>
<li id="google_play_store"><a href="https://play.google.com/store/apps/details?id=com.zacks.androidapp&amp;utm_source=zacks.com&amp;utm_campaign=ZacksFooter&amp;pcampaignid=MKT-Other-global-all-co-prtnr-py-PartBadge-Mar2515-1" title="Download our Zacks App from Google Play"><img alt="Download our Zacks App from Google Play" height="60" src="https://play.google.com/intl/en_us/badges/images/generic/en_badge_web_generic.png" width="154"/></a></li>
</ul>
</nav>
</div>
</div>
</section>
</div>
<!--MSG:20703--><div id="zacks_reported">
<section>
<div id="partners">
<h2>Zacks Research is Reported On:</h2>
<ul>
<li id="msn">MSN</li>
<li id="marketwatch_reported">Marketwatch</li>
<li id="nasdaq">Nasdaq</li>
<li id="forbes">Forbes</li>
<li id="investors">Investors.com</li>
<li id="morningstar">Morningstar</li>
</ul>
</div>
<div id="a360-badge"><a class="newwin" href="https://allyant.com"><img alt="Reviewed by Allyant for accessibility" height="60" src="https://staticx.zacks.com/images/zacks/badges/Reviewed-by-Allyant-for-Accessibility-Badge-White.png" width="60"></img></a></div>
<div id="bbb">
<div id="bbb-logo"><a class="newwin" href="https://www.bbb.org/chicago/business-reviews/financial-services/zacks-investment-research-inc-in-chicago-il-86000393/#sealclick" rel="nofollow"><img alt="ACCREDITED BUSINESS. BBB Rating A+ As of 11/19/2024. Click for profile" height="52" src="https://seal-chicago.bbb.org/seals/blue-seal-250-52-bbb-86000393.png" style="border: 0;" widget="250"></img></a></div>
</div>
</section>
</div>
<!--MSG:14023--><div id="copyright">
<section>
<p>This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones &amp; Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.</p>
<p>Copyright 2024 Zacks Investment Research <span aria-hidden="true">|</span> 10 S Riverside Plaza Suite #1600 <span aria-hidden="true">|</span> Chicago, IL 60606</p>
<p>At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&amp;P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.</p>
<p>Visit <a class="in_copy" href="/performance_disclosure">Performance Disclosure</a> for information about the performance numbers displayed above.</p>
<p>Visit <a class="in_copy newwin" href="http://www.zacksdata.com">www.zacksdata.com</a> to get our data and content for your mobile app or website.</p>
<p>Real time prices by BATS. Delayed quotes by Sungard.</p>
<p>NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.</p>
<p id="recaptcha-statement">This site is protected by reCAPTCHA and the Google <a class="in_copy newwin" href="/privacy">Privacy Policy</a>, <a class="in_copy newwin" href="/dmca.php">DMCA Policy</a> and <a class="in_copy newwin" href="/terms_of_service">Terms of Service</a> apply.</p>
</section>
</div>
<!--MSG:20963-->
<!-- z2_footer end -->
<!-- End: Footer -->
</footer>
<!-- bottomColl Part Start-->
<!-- z2_foot_module start -->

<!-- Google tag (gtag.js) -->


<!-- Google tag (gtag.js) End --><!--
 * <p>This file is used for Yahoo remarketing pixel add </p>
 *
 * @package Generator
 * @subpackage Static
 *
 * @author Arpita Bannerjee
 *
 * @copyright (c) 2015 - 2016 Zacks Investment Research
 * @license   Internal Use only. No License granted.
 *
 * @filesource
 *
 *
-->
<!-- Facebook Pixel Code -->

<noscript><img alt="" height="1" src="https://www.facebook.com/tr?id=532984783731823&amp;ev=PageView&amp;noscript=1" style="display:none" width="1"/></noscript>
<!-- End Facebook Pixel Code --><!-- Start  Countdown Code -->
<section class="logout-timer--modal" id="inactivity_warning">
<div class="modal-content">
<h2 class="modal-title">
                Due to inactivity, you will be<br/>signed out in approximately:  
            </h2>
<div id="countdown"></div>
<div class="modal-footer">
<button class="green btn success" id="inactivity_btn_open">CLICK TO CONTINUE WORKING</button>
</div>
</div>
</section>
<!-- End  Countdown Code -->
<!-- daily data: 1731927630 -->
<!-- real-time data: 1731967200 -->
<!-- ELK JS -->
<!-- Start Outbrain Tag  -->

<!-- End Outbrain Tag  --><!-- Taboola Pixel Code -->

<!-- End of Taboola Pixel Code -->
<!-- Global Taboola Pixel Code -->

<!-- End of Global Taboola Pixel Code -->
<!-- z2_foot_module end -->
<!-- bottomColl Part End-->
</body>
</html>
